Customizing the LASIK flap

Article

Performing LASIK surgery that is customized for each eye can offer more pleasing outcomes in terms of both patient safety and comfort, claims Kerry K. Assil, MD.

Key Points

Customizing parameters such as thickness, diameter, shape, hinge-width and side-cut architecture of the flap in a LASIK procedure is a new development that has been proven to maximize residual corneal thickness, which also decreases the risk of post-LASIK ectasia. We refer to the control of this constellation of variables as Custom-Tailored All Laser LASIK.

Can we mimic the eye's natural anatomy?

We have been very excited about femtosecond technology, because these lasers can cut thin flaps precisely, further reducing the likelihood of ectasia. The technology also offers us the possibility of reducing the incidence of dry eye and decreasing enhancement rates, and facilitates the performance of future enhancements. The widened hinge capability further reduces the potential for epithelial ingrowth or formation of striae.

Superior vs. temporal

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.